FFO
GSK icon

Fortitude Family Office’s GSK GSK Stock Holding History

Fortitude Family Office’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-24
Closed -$1.04K – 2003
2025
Q3 		$1.04K Hold
24
– – ﹤0.01% 1530
2025
Q2 		$922 Hold
24
– – ﹤0.01% 1556
2025
Q1 		$930 Buy
+24
New +$879 ﹤0.01% 1026
2024
Q4 		– Sell
-1,017
Closed -$41.6K – 1329
2024
Q3 		$41.6K Buy
+1,017
New +$41.6K 0.02% 274

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fortitude Family Office's GSK Position: Q4 2025 in Review

Fortitude Family Office sold out of GSK (GSK) in Q4 2025, closing a stake of 24 shares — an estimated $1.04K sold.

Fortitude Family Office first reported a position in GSK in Q3 2024 and held it in 4 quarters. The position peaked at $41.6K in Q3 2024. 998 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

  • Fortitude Family Office reported no remaining GSK position as of Q4 2025 after selling out during the quarter.
  • Fortitude Family Office sold 24 GSK shares in Q4 2025, an estimated $1.04K.
  • Fortitude Family Office first reported a position in GSK in Q3 2024 and held it in 4 quarters.
  • Fortitude Family Office's GSK position peaked at $41.6K in Q3 2024.
  • 998 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on Fortitude Family Office's 13F filing for Q4 2025, filed 15 Jan 2026.